Emergent Biosolutions, Inc. EBS
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-12T03:08:43.664Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.003205013Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T03:08:43.327350+00:00
Emergent Biosolutions, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | 7.37 | 428.2% | 19.1% | |||
| 55Δ | 6.01 | 106.8% | 6.4% | 7.62 | 384.7% | 15.4% |
| 60Δ | 7.87 | 341.2% | 11.7% | |||
| 65Δ | 8.10 | 306.8% | 9.0% | |||
| 70Δ | ||||||
| 75Δ | 4.93 | 564.1% | 22.4% | |||
| 80Δ | 4.33 | 487.8% | 13.9% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.37
- IV
- 428.2%
- B/E move
- 19.1%
55Δ
- Pseudo strike
- 6.01
- IV
- 106.8%
- B/E move
- 6.4%
- Pseudo strike
- 7.62
- IV
- 384.7%
- B/E move
- 15.4%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.87
- IV
- 341.2%
- B/E move
- 11.7%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.10
- IV
- 306.8%
- B/E move
- 9.0%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 4.93
- IV
- 564.1%
- B/E move
- 22.4%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 4.33
- IV
- 487.8%
- B/E move
- 13.9%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 112.90% | |
| 97.67% | |
| 107.16% | |
| 122.00% | |
| 142.59% | |
| 151.15% | |
| 135.00% | |
| 139.44% | |
| 124.64% | |
| 101.93% |
Drug Manufacturers - Specialty & Generic
ELAN
Description unavailable
More →EOLS
Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in…
More →ETON
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park,…
More →GLAS
Description unavailable
More →HCM
HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. The company is headquartered in Central,…
More →HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San…
More →